Tops & Flops Stocks
| Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | -1.000% | 1.596% | -4.500% | 13.018% | -5.911% | - | - |
| Sage Therapeutics Inc. | -1.020% | 7.851% | -25.000% | -69.792% | -34.750% | -79.867% | - |
| Sarepta Therapeutics | -1.040% | 7.962% | -1.331% | 6.460% | 34.098% | 101.306% | 13.432% |
| Johnson & Johnson | -1.050% | -2.434% | -7.599% | -8.843% | -4.336% | 0.103% | 7.508% |
| Cytosorbents Corp. | -1.060% | -1.166% | -13.785% | -65.938% | -22.222% | -90.065% | - |
| Luna Innovations Inc. | -1.080% | - | - | - | - | - | - |
| Chinook Therapeutics Inc. | -1.090% | - | - | - | - | - | - |
| Centene Corp. | -1.100% | -3.314% | -5.296% | 9.984% | 3.069% | 33.689% | 48.288% |
| Galmed Pharmaceuticals Ltd. | -1.100% | -6.522% | 13.158% | 23.741% | -21.101% | - | - |
| Gilead Sciences Inc | -1.100% | -2.584% | -10.361% | -18.145% | -16.466% | 15.748% | 5.492% |
| Alnylam Pharmace. | -1.130% | 0.372% | -2.565% | -25.497% | -23.814% | 17.261% | 72.685% |
| Organovo Holdings Inc. | -1.140% | 5.608% | 3.958% | -43.870% | -2.729% | -86.042% | -94.330% |
| Celldex Therapeutics | -1.160% | -3.825% | -8.808% | 7.317% | -2.762% | 39.572% | 562.900% |
| Blueprint Medicines Corp | -1.170% | -0.719% | -2.682% | 84.569% | 3.806% | 6.730% | - |
| Merck KGaA | -1.200% | -2.756% | -9.330% | -8.940% | 2.952% | 1.264% | 55.967% |
| Biolife Solutions Inc | -1.220% | 2.532% | -5.814% | 3.846% | 8.725% | -43.357% | 7.871% |
| Viatris Inc. | -1.230% | 0.417% | -1.891% | 28.161% | 11.208% | -2.015% | -54.813% |
| Syros Pharmaceuticals Inc. | -1.260% | -2.490% | -12.963% | 84.314% | -28.788% | -90.600% | - |
| Horizon Pharma plc | -1.270% | - | - | - | - | - | - |
| Hms Holdings Corp. | -1.270% | - | - | - | - | - | - |
| BioMarin Pharmaceutical Inc. | -1.280% | -11.239% | -6.593% | -13.214% | -13.807% | 16.759% | 1.258% |